Editorial commentary: Weight loss for cardiovascular disease prevention – is semaglutide the answer?

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	167-169
Number of pages	3
Journal	Trends in Cardiovascular Medicine
Volume	33
Issue number	3
DOIs	https://doi.org/10.1016/j.tcm.2021.12.018
State	Published - Apr 2023
Externally published	Yes

Access to Document

@article{0c6db4129ec24472b029355a6cb64e6c,

title = "Editorial commentary: Weight loss for cardiovascular disease prevention – is semaglutide the answer?",

author = "Lavie, \{Carl J.\} and Bhatt, \{Deepak L.\} and Neeland, \{Ian J.\} and Heymsfield, \{Steven B.\}",

year = "2023",

month = apr,

doi = "10.1016/j.tcm.2021.12.018",

language = "English",

volume = "33",

pages = "167--169",

journal = "Trends in Cardiovascular Medicine",

issn = "1050-1738",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Editorial commentary

T2 - Weight loss for cardiovascular disease prevention – is semaglutide the answer?

AU - Lavie, Carl J.

AU - Bhatt, Deepak L.

AU - Neeland, Ian J.

AU - Heymsfield, Steven B.

PY - 2023/4

Y1 - 2023/4

UR - https://www.scopus.com/pages/publications/85123740738

U2 - 10.1016/j.tcm.2021.12.018

DO - 10.1016/j.tcm.2021.12.018

M3 - Editorial

C2 - 34999021

AN - SCOPUS:85123740738

SN - 1050-1738

VL - 33

SP - 167

EP - 169

JO - Trends in Cardiovascular Medicine

JF - Trends in Cardiovascular Medicine

IS - 3

ER -